“Incidence of central nervous system metastases in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with trastuzumab: A meta-analysis”, Clinics, vol. 76, p. e2653, Aug. 2021, doi: 10.6061/clinics/2021/e2653.